Upgrade to SI Premium - Free Trial

vTv Therapeutics (VTVT)

33.16 -1.19 (3.46%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26 *Est.)

Latest Headlines

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 2, 2026 4:05 PM - StreetInsider vTv Therapeutics (VTVT) PT Lowered to $45 at H.C. Wainwright May 14, 2026 6:42 AM - StreetInsider Form 424B2 vTv Therapeutics Inc. May 13, 2026 5:22 PM - SEC Filing Form 8-K vTv Therapeutics Inc. For: May 13 May 13, 2026 5:21 PM - SEC Filing Form S-8 vTv Therapeutics Inc. May 13, 2026 5:19 PM - SEC Filing Form 10-Q vTv Therapeutics Inc. For: Mar 31 May 13, 2026 4:22 PM - SEC Filing Form 8-K vTv Therapeutics Inc. For: May 13 May 13, 2026 4:20 PM - SEC Filing vTv Therapeutics (VTVT) Tops Q1 EPS by 165c May 13, 2026 4:19 PM - StreetInsider vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update May 13, 2026 4:01 PM - StreetInsider vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) May 8, 2026 4:15 PM - StreetInsider vTv Therapeutics to Participate in Upcoming May Investor Conferences May 7, 2026 8:00 AM - Globe NewsWire Form DEF 14A vTv Therapeutics Inc. For: Jun 10 April 28, 2026 4:22 PM - SEC Filing Form SCHEDULE 13G/A vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC April 16, 2026 5:15 PM - SEC Filing BTIG Reiterates Buy Rating on vTv Therapeutics (VTVT): 'VTVT checks every box' April 13, 2026 12:29 PM - StreetInsider vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) April 7, 2026 4:15 PM - StreetInsider Form SCHEDULE 13G vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC March 27, 2026 4:45 PM - SEC Filing vTv Therapeutics to Participate in the 38th Annual ROTH Conference March 16, 2026 8:00 AM - StreetInsider Evercore ISI Starts vTv Therapeutics (VTVT) at Outperform, 'essentially a single-asset story' March 12, 2026 6:43 AM - StreetInsider BTIG Reiterates Buy Rating on vTv Therapeutics (VTVT): "Street overlooking small molecule portfolio" March 11, 2026 11:09 AM - StreetInsider Form 8-K vTv Therapeutics Inc. For: Mar 10 March 10, 2026 4:38 PM - SEC Filing Form 8-K vTv Therapeutics Inc. For: Mar 10 March 10, 2026 4:36 PM - SEC Filing Form 10-K vTv Therapeutics Inc. For: Dec 31 March 10, 2026 4:33 PM - SEC Filing vTv Therapeutics (VTVT) Tops Q3 EPS by 42c March 10, 2026 4:10 PM - StreetInsider vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update March 10, 2026 4:01 PM - StreetInsider Full Article List